Another bill designed to make taxpayer-funded research available raises old questions and familiar divides. Does it have a chance of generating a productive decision?
In a business environment characterized by risks, upstart innovations, and even contempt for the law, publishers have to ward off threats the old-fashioned way, by out-innovating their rivals and preempting new services.
The firestorm around the Research Works Act forces Elsevier to back away. Where does that leave the rest of us?
Can we learn a lesson from a prior clash of RWA and FRPAA years ago?
When it comes to discussions about access, the silent majority focused on doing science is presented with real choices, not all of which square with the scorched-earth rhetoric that too often dominates.